{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T01:07:12Z","timestamp":1775005632816,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.urolonc.2016.04.001","type":"journal-article","created":{"date-parts":[[2016,5,11]],"date-time":"2016-05-11T09:17:45Z","timestamp":1462958265000},"page":"417.e9-417.e15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["De Ritis (aspartate transaminase\/alanine transaminase) ratio as a significant predictor of recurrence-free survival in patients with upper urinary tract urothelial carcinoma following nephroureterectomy"],"prefix":"10.1016","volume":"34","author":[{"given":"Masatomo","family":"Nishikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2016.04.001_bib1","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1464-410X.2010.09675.x","article-title":"Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973\u20132005","volume":"107","author":"Raman","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2016.04.001_bib2","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/cncr.24135","article-title":"Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration","volume":"115","author":"Margulis","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2016.04.001_bib3","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/ncpuro0875","article-title":"Management of patients with upper urinary tract transitional cell carcinoma","volume":"4","author":"Raman","year":"2007","journal-title":"Natl Clin Pract Urol"},{"key":"10.1016\/j.urolonc.2016.04.001_bib4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.eururo.2012.02.030","article-title":"Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature","volume":"62","author":"Lughezzani","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2016.04.001_bib5","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.tox.2007.11.021","article-title":"The current state of serum biomarkers of hepatotoxicity","volume":"245","author":"Ozer","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.urolonc.2016.04.001_bib6","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0009-8981(57)90027-X","article-title":"An enzymic test for the diagnosis of viral hepatitis: the transaminase serum activities","volume":"2","author":"De Ritis","year":"1957","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.urolonc.2016.04.001_bib7","first-page":"117","article-title":"The de ritis ratio: the test of time","volume":"34","author":"Botros","year":"2013","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.urolonc.2016.04.001_bib8","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/bjc.1990.133","article-title":"An overview of prognostic factors in small cell lung cancer. A report from the Subcommittee for the Management of Lung Cancer of the United Kingdom Coordinating Committee on Cancer Research","volume":"61","author":"Rawson","year":"1990","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urolonc.2016.04.001_bib9","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.bjc.6604568","article-title":"Modelling prognostic factors in advanced pancreatic cancer","volume":"99","author":"Stocken","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urolonc.2016.04.001_bib10","first-page":"1892","article-title":"Prognostic factors of distal cholangiocarcinoma after curative surgery: a series of 84 cases","volume":"60","author":"Tan","year":"2013","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.urolonc.2016.04.001_bib11","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.juro.2015.01.083","article-title":"The preoperative AST\/ALT (De Ritis) ratio represents a poor prognostic factor in a cohort of patients with nonmetastatic renal cell carcinoma","volume":"194","author":"Bezan","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2016.04.001_bib12","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1089\/end.2007.0154","article-title":"Retroperitoneoscopic nephroureterectomy for upper urinary tract cancer: a comparative study with conventional open retroperitoneal nephroureterectomy","volume":"22","author":"Terakawa","year":"2008","journal-title":"J Endourol"},{"key":"10.1016\/j.urolonc.2016.04.001_bib13","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/0277-5379(90)90080-D","article-title":"Liver metastases from breast cancer: the relationship between clinical, biochemical and pathological features, and survival","volume":"26","author":"O\u2019Reilly","year":"1990","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.urolonc.2016.04.001_bib14","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/bimj.200410135","article-title":"Estimation of the Youden Index and its associated cutoff point","volume":"47","author":"Fluss","year":"2005","journal-title":"Biom J"},{"key":"10.1016\/j.urolonc.2016.04.001_bib15","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.urolonc.2016.04.001_bib16","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.cell.2008.08.021","article-title":"Cancer cell metabolism: Warburg and beyond","volume":"134","author":"Hsu","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.urolonc.2016.04.001_bib17","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00345-011-0710-3","article-title":"Predictive factors of recurrence and survival of upper tract urothelial carcinomas","volume":"29","author":"Verhoest","year":"2001","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2016.04.001_bib18","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.urology.2008.07.042","article-title":"Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study","volume":"73","author":"Fern\u00e1ndez","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2016.04.001_bib19","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.eururo.2011.05.049","article-title":"Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy","volume":"60","author":"Ouzzane","year":"2011","journal-title":"Eur Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143916300096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143916300096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:08:53Z","timestamp":1761041333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143916300096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S1078143916300096"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2016.04.001","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"De Ritis (aspartate transaminase\/alanine transaminase) ratio as a significant predictor of recurrence-free survival in patients with upper urinary tract urothelial carcinoma following nephroureterectomy","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2016.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}